Nir Hacohen
0000-0002-2349-2656
Publication & Citation Trends
Publications
604 total
CRISPR screens identify targets to rescue age-related T cell dysfunction in cancer
Cited by 0
Semantic Scholar
Abstract 7411: Proteotranscriptomic dissection of breast cancer T cell states identifies CD103+ Tfh-derived cytotoxic CD4+ cells linked to immunotherapy response
Cited by 0
Semantic Scholar
Abstract 2559: Identifying cancer cell intrinsic regulators of radiation-induced interferon signaling
Cited by 0
Semantic Scholar
Proteotranscriptomic Dissection of Breast Cancer T Cell States Identifies CD103+ Tfh-derived Cytotoxic Cells Linked to Immunotherapy Response
Cited by 0
Semantic Scholar
An affinity reagent-conjugated biotin ligase for amplified cell surface labelling in vitro and in vivo
Cited by 0
Semantic Scholar
Training Tomorrow's Leaders in Cancer Immunology.
Cited by 0
Semantic Scholar
Sensitive detection of cancer antigens enabled by user-defined peptide libraries.
Cited by 1
Semantic Scholar
Research Topics
Cancer Immunotherapy and Biomarkers
(118)
Immunotherapy and Immune Responses
(106)
Single-cell and spatial transcriptomics
(82)
Immune Cell Function and Interaction
(79)
T-cell and B-cell Immunology
(67)
Affiliations
Broad Institute
Boston University
Brigham and Women's Hospital
Novartis (Switzerland)
Merck & Co., Inc., Rahway, NJ, USA (United States)